Dai-ichi Life Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-243,509
Closed -$19.5M 260
2016
Q3
$19.5M Buy
243,509
+3,269
+1% +$262K 0.59% 29
2016
Q2
$18.9M Buy
240,240
+102,372
+74% +$7.71M 0.57% 32
2016
Q1
$9.93M Sell
137,868
-848
-0.6% -$64.2K 0.3% 73
2015
Q4
$11.7M Sell
138,716
-3,874
-3% -$321K 0.37% 56
2015
Q3
$11.9M Buy
142,590
+1,169
+0.8% +$98.7K 0.37% 52
2015
Q2
$11.8M Sell
141,421
-86,203
-38% -$6.57M 0.35% 55
2015
Q1
$16.5M Buy
227,624
+39,754
+21% +$2.83M 0.47% 43
2014
Q4
$13M Buy
187,870
+4,791
+3% +$323K 0.37% 52
2014
Q3
$11.9M Buy
183,079
+8,017
+5% +$508K 0.35% 54
2014
Q2
$10.9M Buy
175,062
+5,710
+3% +$341K 0.34% 63
2014
Q1
$9.97M Sell
169,352
-1,967
-1% -$110K 0.32% 72
2013
Q4
$8.74M Sell
171,319
-3,051
-2% -$153K 0.27% 90
2013
Q3
$8.78M Sell
174,370
-7,064
-4% -$370K 0.31% 78
2013
Q2
$8.91M Buy
+181,434
New +$9.87M 0.31% 72

Other funds holding LLY

Dai-ichi Life Holdings's LLY Position: Q4 2016 in Review

Dai-ichi Life Holdings sold out of Eli Lilly (LLY) in Q4 2016, closing a stake of 243,509 shares — an estimated $19.5M sold.

Dai-ichi Life Holdings first reported a position in LLY in Q2 2013 and held it in 14 quarters. The position peaked at $19.5M in Q3 2016. 1,212 funds tracked by Wall St. Rank hold LLY as of Q4 2016.

  • Dai-ichi Life Holdings reported no remaining Eli Lilly position as of Q4 2016 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 243,509 Eli Lilly shares in Q4 2016, an estimated $19.5M.
  • Dai-ichi Life Holdings first reported a position in Eli Lilly in Q2 2013 and held it in 14 quarters.
  • Dai-ichi Life Holdings's Eli Lilly position peaked at $19.5M in Q3 2016.
  • 1,212 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2016.

Based on Dai-ichi Life Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.